human | Q5 |
P734 | family name | Gerdts | Q37077449 |
Gerdts | Q37077449 | ||
Gerdts | Q37077449 | ||
P735 | given name | Volker | Q1576766 |
Volker | Q1576766 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | male | Q6581097 |
Q94523185 | A Porcine Model of Zika Virus Infection to Profile the In Utero Interferon Alpha Response |
Q42463233 | A comparison between isolated blood dendritic cells and monocyte-derived dendritic cells in pigs |
Q91440678 | A lipidic delivery system of a triple vaccine adjuvant enhances mucosal immunity following nasal administration in mice |
Q38915769 | A lumpy skin disease virus deficient of an IL-10 gene homologue provides protective immunity against virulent capripoxvirus challenge in sheep and goats |
Q38672711 | A novel combination adjuvant platform for human and animal vaccines. |
Q43722893 | A novel vaccine adjuvant comprised of a synthetic innate defence regulator peptide and CpG oligonucleotide links innate and adaptive immunity |
Q38677197 | Adjuvants for veterinary vaccines--types and modes of action |
Q40250122 | Administration of Poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) and Avian Beta Defensin as Adjuvants in Inactivated Inclusion Body Hepatitis Virus and its Hexon Protein-Based Experimental Vaccine Formulations in Chickens |
Q43739433 | Administration of poly[di(sodium carboxylatoethylphenoxy)]phosphazene (PCEP) as adjuvant activated mixed Th1/Th2 immune responses in pigs |
Q50578339 | All three classes of CpG ODNs up-regulate IP-10 gene in pigs. |
Q40524902 | Analysis of immune responses to recombinant proteins from strains of Mycoplasma mycoides subsp. mycoides, the causative agent of contagious bovine pleuropneumonia |
Q38067243 | Animal models for neonatal diseases in humans |
Q36028001 | Antibody and Cytokine Responses of Koalas (Phascolarctos cinereus) Vaccinated with Recombinant Chlamydial Major Outer Membrane Protein (MOMP) with Two Different Adjuvants |
Q34890075 | Antibody response specific to the capsular polysaccharide is impaired in Streptococcus suis serotype 2-infected animals |
Q83151639 | Antibody responses in adult and neonatal BALB/c mice to immunization with novel Bordetella pertussis vaccine formulations |
Q37810793 | Biological roles of host defense peptides: lessons from transgenic animals and bioengineered tissues |
Q38629725 | CD71+ erythroid suppressor cells impair adaptive immunity against Bordetella pertussis. |
Q34290818 | Canadian Adjuvant Initiative Workshop, March 26-27, 2013--Ottawa, Canada |
Q38090219 | Capripoxvirus-vectored vaccines against livestock diseases in Africa. |
Q40586201 | Capsular polysaccharide from Mycoplasma mycoides subsp. mycoides shows potential for protection against contagious bovine pleuropneumonia |
Q38065559 | Carrier molecules for use in veterinary vaccines |
Q35826657 | Caspase-1 Dependent IL-1β Secretion and Antigen-Specific T-Cell Activation by the Novel Adjuvant, PCEP. |
Q37821483 | Combination adjuvants: the next generation of adjuvants? |
Q33291765 | Commensal bacteria and expression of two major intestinal chemokines, TECK/CCL25 and MEC/CCL28, and their receptors |
Q44877345 | Contribution of the swine model in the study of human sexually transmitted infections |
Q45324576 | Corrigendum to "Zika Virus Causes Persistent Infection in Porcine Conceptuses and May Impair Health in Offspring". |
Q44929230 | CpG oligodeoxynucleotides activate innate immune response that suppresses infectious bronchitis virus replication in chicken embryos |
Q42206659 | CpG-ODNs induced changes in cytokine/chemokines genes expression associated with suppression of infectious bronchitis virus replication in chicken lungs |
Q84957757 | CpG-Recoding in Zika Virus Genome Causes Host-Age-Dependent Attenuation of Infection With Protection Against Lethal Heterologous Challenge in Mice |
Q40569357 | DNA vaccination in utero: a new approach to induce protective immunity in the newborn |
Q84208638 | Differential activation and maturation of two porcine DC populations following TLR ligand stimulation |
Q44449501 | Does adjuvanticity depend on the ability to recruit specific immune cells? |
Q37224019 | Early immune response following Salmonella enterica subspecies enterica serovar Typhimurium infection in porcine jejunal gut loops |
Q37546452 | Enzymatic modification of lipid A by ArnT protects Bordetella bronchiseptica against cationic peptides and is required for transmission. |
Q40811628 | Experimental evaluation of inactivated and live attenuated vaccines against Mycoplasma mycoides subsp. mycoides |
Q53767845 | Expression of TECK/CCL25 and MEC/CCL28 chemokines and their respective receptors CCR9 and CCR10 in porcine mucosal tissues. |
Q51996236 | Expression of mucosal chemokines TECK/CCL25 and MEC/CCL28 during fetal development of the ovine mucosal immune system. |
Q42245234 | Failure of a VapA/CpG oligodeoxynucleotide vaccine to protect foals against experimental Rhocococcus equi pneumonia despite induction of VapA-specific antibody and interferon-γ response |
Q39594585 | Future vaccines for a globalized world |
Q58615671 | High dosage of zinc modulates T-cells in a time-dependent manner within porcine gut-associated lymphatic tissue |
Q37257486 | Humoral and cellular factors of maternal immunity in swine. |
Q39021470 | Immune responses to in ovo vaccine formulations containing inactivated fowl adenovirus 8b with poly[di(sodium carboxylatoethylphenoxy)]phosphazene (PCEP) and avian beta defensin as adjuvants in chickens |
Q33757880 | Immunization of a wild koala population with a recombinant Chlamydia pecorum Major Outer Membrane Protein (MOMP) or Polymorphic Membrane Protein (PMP) based vaccine: New insights into immune response, protection and clearance |
Q44769788 | Immunization with PCEP microparticles containing pertussis toxoid, CpG ODN and a synthetic innate defense regulator peptide induces protective immunity against pertussis |
Q58556925 | In Ovo Administration of Innate Immune Stimulants and Protection from Early Chick Mortalities due to Yolk Sac Infection |
Q48055540 | Induction, regulation and physiological role of IL-17 secreting helper T-cells isolated from PBMC, thymus, and lung lymphocytes of young pigs |
Q40417195 | Infection with Bordetella parapertussis but not Bordetella pertussis causes pertussis-like disease in older pigs |
Q46326832 | Influence of maternal antibodies on active pertussis toxoid immunization of neonatal mice and piglets |
Q89514925 | Innate immunemodulator containing adjuvant formulated HA based vaccine protects mice from lethal infection of highly pathogenic avian influenza H5N1 virus |
Q49898999 | Intradermal immunization with inactivated swine influenza virus and adjuvant polydi(sodium carboxylatoethylphenoxy)phosphazene (PCEP) induced humoral and cell-mediated immunity and reduced lung viral titres in pigs |
Q40185695 | Intranasal vaccination with an adjuvanted polyphosphazenes nanoparticle-based vaccine formulation stimulates protective immune responses in mice |
Q38492768 | Large animal models for vaccine development and testing. |
Q34601948 | Maternal immunity provides protection against pertussis in newborn piglets |
Q42623410 | Molecular cloning and functional characterization of porcine CCL28: possible involvement in homing of IgA antibody secreting cells into the mammary gland. |
Q38195758 | Mouse and pig models for studies of natural and vaccine-induced immunity to Bordetella pertussis. |
Q36447720 | Mucosal delivery of vaccines in domestic animals |
Q37833985 | Multistage vaccines containing outer membrane, type III secretion system and inclusion membrane proteins protects against a Chlamydia genital tract infection and pathology |
Q42320290 | Neonatal pigs are susceptible to experimental Zika virus infection |
Q45927257 | New insights into the dual recruitment of IgA+ B cells in the developing mammary gland. |
Q42262598 | Novel vaccine formulations against pertussis offer earlier onset of immunity and provide protection in the presence of maternal antibodies |
Q37872669 | Oral DNA vaccination in utero induces mucosal immunity and immune memory in the neonate |
Q35170057 | Oral antigen exposure in newborn piglets circumvents induction of oral tolerance in response to intraperitoneal vaccination in later life. |
Q34116871 | PCEP enhances IgA mucosal immune responses in mice following different immunization routes with influenza virus antigens |
Q43464015 | PCPP (poly[di(carboxylatophenoxy)-phosphazene]) microparticles co-encapsulating ovalbumin and CpG oligo-deoxynucleotides are potent enhancers of antigen specific Th1 immune responses in mice |
Q43491506 | Pathotypic and molecular characterization of a fowl adenovirus associated with inclusion body hepatitis in Saskatchewan chickens |
Q56381178 | Persistent Zika virus infection in porcine conceptuses is associated with elevated in utero cortisol levels |
Q37534284 | Peste des petits ruminants virus tissue tropism and pathogenesis in sheep and goats following experimental infection |
Q34716772 | Porcine neonatal blood dendritic cells, but not monocytes, are more responsive to TLRs stimulation than their adult counterparts |
Q40650298 | Protection of neonates and infants by maternal immunization |
Q40342590 | Protective Role of Passively Transferred Maternal Cytokines against Bordetella pertussis Infection in Newborn Piglets |
Q43781942 | Protein chimeras containing the Mycoplasma bovis GAPDH protein and bovine host-defence peptides retain the properties of the individual components |
Q40760184 | Recombinant Mycoplasma mycoides proteins elicit protective immune responses against contagious bovine pleuropneumonia |
Q96434028 | Regional Dichotomy in Enteric Mucosal Immune Responses to a Persistent Mycobacterium avium ssp. paratuberculosis Infection |
Q36758318 | S1 domain of the porcine epidemic diarrhea virus spike protein as a vaccine antigen |
Q37834135 | Safety and immunogenicity of a prototype anti-Chlamydia pecorum recombinant protein vaccine in lambs and pregnant ewes. |
Q83483082 | Stability of expression of reference genes in porcine peripheral blood mononuclear and dendritic cells |
Q57198394 | Strategies to Stimulate Innate Immunity for Designing Effective Vaccine Adjuvants |
Q38358558 | Strategies to link innate and adaptive immunity when designing vaccine adjuvants |
Q78177266 | Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring. |
Q89967837 | Susceptibility of Chicken Embryos, Sheep, Cattle, Pigs, and Chickens to Zika Virus Infection |
Q92243227 | Synthetic Cationic Peptide IDR-1002 and Human Cathelicidin LL37 Modulate the Cell Innate Response but Differentially Impact PRRSV Replication in vitro |
Q92151381 | The African strain of Zika virus causes more severe in utero infection than Asian strain in a porcine fetal transmission model |
Q36962817 | The benefits of using diverse animal models for studying pertussis. |
Q34492573 | The host defense peptide beta-defensin 1 confers protection against Bordetella pertussis in newborn piglets |
Q37966290 | The pig: a model for human infectious diseases |
Q37622995 | The potential of polyphosphazenes for delivery of vaccine antigens and immunotherapeutic agents |
Q48003495 | Toll-like receptor 4 variants reduce airway response in human subjects at high endotoxin levels in a swine facility. |
Q37015991 | Use of animal models in the development of human vaccines |
Q55472927 | Vaccination of koalas (Phascolarctos cinereus) against Chlamydia pecorum using synthetic peptides derived from the major outer membrane protein. |
Q37843628 | Vaccination of koalas (Phascolarctos cinereus) with a recombinant chlamydial major outer membrane protein adjuvanted with poly I:C, a host defense peptide and polyphosphazine, elicits strong and long lasting cellular and humoral immune responses. |
Q35826767 | Vaccine Potentiation by Combination Adjuvants |
Q38783240 | Vaccines for porcine epidemic diarrhea virus and other swine coronaviruses |
Q37356542 | Veterinary vaccines: alternatives to antibiotics? |
Q43046870 | Zika Virus Causes Persistent Infection in Porcine Conceptuses and may Impair Health in Offspring |
Q95929052 | Zika Virus with Increased CpG Dinucleotide Frequencies Shows Oncolytic Activity in Glioblastoma Stem Cells |
Q34343647 | c-di-GMP enhances protective innate immunity in a murine model of pertussis |
Search more.